Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06728228 · ClinicalTrials.gov registry record · NA
Amnioinfusion for Fetal Renal Failure
A NA study of Polycystic Kidney Disease and Lower Urinary Tract Obstructive Syndrome, sponsored by Fetal Care Center, P.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06728228: Recruiting NA study of Polycystic Kidney Disease and Lower Urinary Tract Obstructive Syndrome, sponsored by Fetal Care Center, P.
NCT06728228 is a NA study of Polycystic Kidney Disease and Lower Urinary Tract Obstructive Syndrome that is actively recruiting participants, run by Fetal Care Center, P. The registered enrollment target is 35 participants, below the 326-participant average among 5 other Polycystic Kidney Disease trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06728228, a NA study of Polycystic Kidney Disease and Lower Urinary Tract Obstructive Syndrome, is actively recruiting participants, sponsored by Fetal Care Center, P.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if serial amnioinfusions can improve the chances of survival for fetuses with severe kidney problems that cause low amniotic fluid (anhydramnios). Low amniotic fluid can affect lung development and may lead to serious health issues for the fetus. The main questions this study aims to answer are: * Can serial amnioinfusion increase the chances of survival for these fetuses? * Does this procedure improve chances of survival until dialysis and/or kidney transplant? Participants will: * Receive regular amnioinfusions, which is a procedure that adds fluid to the amniotic cavity. * Undergo monitoring to check the effects on the fetus and mother. This study will help researchers understand if amnioinfusion is a useful treatment for fetal kidney problems and may provide valuable information for similar cases in the future.
Primary Outcome
Proportion of neonates surviving to \>= 14 days and placement of dialysis access after serial amnioinfusions (defined as use of a dialysis catheter for \>=14 continuous days)
Conditions Studied
Interventions
- OTHER Amnioinfusion
Study Locations (1)
Texas
- Fetal Care Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2024-12-05 |
| Est. Completion | 2026-11-15 |
| Phase | NA |
What NCT06728228 shows while recruiting
NCT06728228 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 326-participant average among 5 other Polycystic Kidney Disease trials with a reported enrollment target (89% lower).
The record links to 9 conditions, with Polycystic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Amnioinfusion is the first listed.
NCT06728228 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06728228 about?
NCT06728228 is a clinical study titled "Amnioinfusion for Fetal Renal Failure". The goal of this clinical trial is to learn if serial amnioinfusions can improve the chances of survival for fetuses with severe kidney problems that cause low amniotic fluid (anhydramnios). Low amniotic fluid can affect lung development and may lead to serious health issues for the fetus. The main ...
What is the current status of trial NCT06728228?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2024-12-05. Estimated completion is 2026-11-15.
What conditions does trial NCT06728228 study?
This clinical trial studies the following conditions: Polycystic Kidney Disease, Lower Urinary Tract Obstructive Syndrome, Multicystic Dysplastic Kidney, Fetal Renal Anomaly, Anhydramnios.
What interventions are being tested in trial NCT06728228?
The interventions under investigation include: Amnioinfusion (OTHER).
Who is sponsoring clinical trial NCT06728228?
This trial is sponsored by Fetal Care Center, P, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06728228 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polycystic Kidney Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Well-Formulated Ketogenic Diet Polycystic Kidney Disease
RECRUITING · NA
-
PKD Clinical and Translational Core Study
RECRUITING
-
Polycystic Kidney Disease Data Repository
RECRUITING
-
Early PKD Observational Cohort Study
RECRUITING
-
Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI